Literature DB >> 3034206

Cellular changes associated with persistent hepatitis A infection in vitro.

R E Kiernan, J A Marshall, A G Coulepis, D A Anderson, I D Gust.   

Abstract

The rate of division, morphology and ultrastructure of BSC-1 cells, persistently infected with hepatitis A virus (HAV), were compared with uninfected cells for 60 days after splitting of the cells. Both control and infected cells showed a biphasic growth pattern marked firstly by increasing cell density and high mitotic rate (exponential phase) and then high constant cell density and little mitosis (stationary phase). Immunoperoxidase studies showed that hepatitis A antigen (HAAg) appeared as cytoplasmic granules approximately one third of the way through the exponential phase in infected cells. The percentage of cells with HAAg rose until the early stationary phase when virtually all cells contained antigen. Radioimmunoassay demonstrated an increase in HAAg per cell in the stationary phase. Radioimmunofocus assay and immune electron microscopy confirmed the presence of HAV in infected cells in the stationary phase. Thin sectioning electron microscopy showed cytoplasmic annulate lamellae in infected cells of both phases but not in control cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034206     DOI: 10.1007/BF01313727

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

1.  Propagation of human hepatitis A virus in cell culture in vitro.

Authors:  P J Provost; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

2.  The origin of the HM175 strain of hepatitis A virus.

Authors:  I D Gust; N I Lehmann; S Crowe; M McCrorie; S A Locarnini; C R Lucas
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

3.  Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures.

Authors:  L N Binn; S M Lemon; R H Marchwicki; R R Redfield; N L Gates; W H Bancroft
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

Review 4.  Taxonomic classification of hepatitis A virus.

Authors:  I D Gust; A G Coulepis; S M Feinstone; S A Locarnini; Y Moritsugu; R Najera; G Siegl
Journal:  Intervirology       Date:  1983       Impact factor: 1.763

5.  Pathogenesis of oncogenic simian adenoviruses. VII. The origin of annulate lamellae in LLC-MK2 cells infected with SV30.

Authors:  L P Merkow; M Slifkin; M Pardo; N P Rapoza
Journal:  J Ultrastruct Res       Date:  1970-02

6.  Development and changes of annulate lamellae complexes in rubella virus-infected RK-13 cells.

Authors:  G Patrizi; J N Middelkamp
Journal:  J Ultrastruct Res       Date:  1970-06

7.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

8.  Electron and immunoelectron microscopic study on liver tissues of marmosets infected with hepatitis A virus.

Authors:  S N Huang; D Lorenz; R J Gerety
Journal:  Lab Invest       Date:  1979-07       Impact factor: 5.662

9.  Persistent infection of human fibroblasts by hepatitis A virus.

Authors:  A Vallbracht; L Hofmann; K G Wurster; B Flehmig
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

10.  Hepatitis A virus in cell culture. II. Growth characteristics of hepatitis A virus in Frhk-4/R cells.

Authors:  B Flehmig
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

View more
  2 in total

1.  Morphological changes in HAV-infected Frp/3 cells and immunolocalization of HAAg.

Authors:  A Tinari; F M Ruggeri; M Divizia; A Panà; G Donelli
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Restricted replication of hepatitis A virus in cell culture: encapsidation of viral RNA depletes the pool of RNA available for replication.

Authors:  D A Anderson; B C Ross; S A Locarnini
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.